Aspen Aerogels (NYSE:ASPN – Get Free Report) had its target price cut by research analysts at Barclays from $25.00 to $13.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the construction company’s stock. Barclays‘s price objective suggests a potential upside of 59.80% from the stock’s current price.
Several other analysts also recently commented on ASPN. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a research note on Wednesday. Canaccord Genuity Group cut their target price on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a research note on Friday, February 14th. Roth Mkm cut their target price on Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating on the stock in a research note on Friday, February 14th. Piper Sandler cut their target price on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Finally, Seaport Res Ptn downgraded Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 12th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $22.44.
Check Out Our Latest Report on ASPN
Aspen Aerogels Stock Down 2.0 %
Aspen Aerogels (NYSE:ASPN – Get Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. On average, analysts anticipate that Aspen Aerogels will post 0.22 EPS for the current fiscal year.
Hedge Funds Weigh In On Aspen Aerogels
Institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. lifted its position in Aspen Aerogels by 5.5% during the fourth quarter. Vanguard Group Inc. now owns 4,360,246 shares of the construction company’s stock valued at $51,800,000 after purchasing an additional 226,251 shares in the last quarter. FMR LLC lifted its position in Aspen Aerogels by 23.6% during the third quarter. FMR LLC now owns 4,050,896 shares of the construction company’s stock valued at $112,169,000 after purchasing an additional 773,647 shares in the last quarter. Oaktop Capital Management II L.P. lifted its position in Aspen Aerogels by 5.6% during the fourth quarter. Oaktop Capital Management II L.P. now owns 3,740,525 shares of the construction company’s stock valued at $44,437,000 after purchasing an additional 200,000 shares in the last quarter. Needham Investment Management LLC lifted its position in Aspen Aerogels by 5.2% during the fourth quarter. Needham Investment Management LLC now owns 2,389,700 shares of the construction company’s stock valued at $28,390,000 after purchasing an additional 117,500 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in Aspen Aerogels by 25.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,018,631 shares of the construction company’s stock valued at $23,983,000 after purchasing an additional 409,862 shares in the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.
Aspen Aerogels Company Profile
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Stories
- Five stocks we like better than Aspen Aerogels
- The 3 Best Retail Stocks to Shop for in August
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- What is a Dividend King?
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Short Selling – The Pros and Cons
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.